-
TRAIL is a novel antiviral protein against dengue virus.
J Virol. 2008 Jan;82(1):555-64
PMID: 17913827
-
Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells.
J Virol. 2003 Nov;77(21):11822-32
PMID: 14557666
-
Dengue virus induces expression of CXC chemokine ligand 10/IFN-gamma-inducible protein 10, which competitively inhibits viral binding to cell surface heparan sulfate.
J Immunol. 2006 Sep 1;177(5):3185-92
PMID: 16920957
-
Summaries of Affymetrix GeneChip probe level data.
Nucleic Acids Res. 2003 Feb 15;31(4):e15
PMID: 12582260
-
Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study.
Am J Trop Med Hyg. 1990 Feb;42(2):179-84
PMID: 2316788
-
Increased expression and a potential anti-inflammatory role of TRAIL in atopic dermatitis.
J Invest Dermatol. 2005 Oct;125(4):746-52
PMID: 16185275
-
Dengue and dengue haemorrhagic fever: implications of host genetics.
FEMS Immunol Med Microbiol. 2006 Jul;47(2):155-66
PMID: 16831202
-
Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C.
Gut. 2006 Mar;55(3):374-9
PMID: 16150856
-
Immunopathogenesis of Dengue hemorrhagic fever.
Virology. 1999 Apr 25;257(1):1-6
PMID: 10208914
-
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression.
J Exp Med. 2000 Apr 3;191(7):1095-104
PMID: 10748228
-
Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered.
Yale J Biol Med. 1970 Apr;42(5):311-28
PMID: 5419206
-
Inflammatory mediators in dengue virus infection in children: interleukin-8 and its relationship to neutrophil degranulation.
Infect Immun. 2000 Feb;68(2):702-7
PMID: 10639436
-
Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction.
J Clin Microbiol. 1992 Mar;30(3):545-51
PMID: 1372617
-
Host gene expression profiling of dengue virus infection in cell lines and patients.
PLoS Negl Trop Dis. 2007 Nov 21;1(2):e86
PMID: 18060089
-
Infection of human primary hepatocytes with dengue virus serotype 2.
J Med Virol. 2007 Mar;79(3):300-7
PMID: 17245728
-
Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production.
Am J Trop Med Hyg. 2000 Jul-Aug;63(1-2):71-5
PMID: 11357999
-
Elevated levels of soluble ST2 protein in dengue virus infected patients.
Cytokine. 2008 Feb;41(2):114-20
PMID: 18226917
-
Early clinical and laboratory indicators of acute dengue illness.
J Infect Dis. 1997 Aug;176(2):313-21
PMID: 9237695
-
Safety and antitumor activity of recombinant soluble Apo2 ligand.
J Clin Invest. 1999 Jul;104(2):155-62
PMID: 10411544
-
Palmitic acid induces IP-10 expression in human macrophages via NF-kappaB activation.
Biochem Biophys Res Commun. 2007 Jun 22;358(1):150-5
PMID: 17467667
-
Dengue virus selectively induces human mast cell chemokine production.
J Virol. 2002 Aug;76(16):8408-19
PMID: 12134044
-
Elevated levels of IL-8 in dengue hemorrhagic fever.
J Med Virol. 1998 Nov;56(3):280-5
PMID: 9783699
-
Both CXCR3 and CXCL10/IFN-inducible protein 10 are required for resistance to primary infection by dengue virus.
J Immunol. 2006 Aug 1;177(3):1855-63
PMID: 16849497
-
Human monocyte chemotactic proteins-2 and -3: structural and functional comparison with MCP-1.
J Leukoc Biol. 1996 Jan;59(1):67-74
PMID: 8558070
-
Elevated serum levels of interferon- gamma -inducible protein-10 in patients coinfected with hepatitis C virus and HIV.
J Infect Dis. 2007 Oct 1;196(7):1053-7
PMID: 17763328
-
Activation of terminally differentiated human monocytes/macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharide.
J Virol. 2002 Oct;76(19):9877-87
PMID: 12208965
-
Joint WHO HQ/SEAROP/WPRO meeting on DengueNet implementation in South-East Asia and the Western Pacific, Kuala Lumpur, 11-13 December 2003.
Wkly Epidemiol Rec. 2003 Sep 26;78(39):346-7
PMID: 15622835
-
Macrophage inflammatory protein-1.
Int J Biochem Cell Biol. 2004 Oct;36(10):1882-6
PMID: 15203102
-
Dengue: the risk to developed and developing countries.
Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2395-400
PMID: 8146129
-
Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis.
J Immunol. 1998 Dec 1;161(11):6338-46
PMID: 9834124
-
TRAIL-R as a negative regulator of innate immune cell responses.
Immunity. 2004 Dec;21(6):877-89
PMID: 15589175
-
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
Methods. 2001 Dec;25(4):402-8
PMID: 11846609
-
MIP-1 alpha and MIP-1 beta induction by dengue virus.
J Med Virol. 2001 Oct;65(2):324-30
PMID: 11536240
-
MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells.
J Gen Virol. 2006 Dec;87(Pt 12):3623-3630
PMID: 17098977
-
Mig and IP-10: CXC chemokines that target lymphocytes.
J Leukoc Biol. 1997 Mar;61(3):246-57
PMID: 9060447
-
TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release.
Blood. 2005 May 1;105(9):3413-9
PMID: 15644410
-
Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity.
BMC Infect Dis. 2008 Jun 25;8:86
PMID: 18578883
-
Chemokine-mediated inflammation: Identification of a possible regulatory role for CCR2.
Mol Immunol. 2007 Mar;44(8):1944-53
PMID: 17081610